Johnson & Johnson (NYSE:JNJ)
Johnson & Johnson (NYSE:JNJ) represented a move of 2.25 percent or $-2.61 per share and closed its previous day trading session at $146.44. 8.24 Million Shares were traded in the last trading session with an Average Volume of 6.82 Million Shares. The stock currently has a Market Capitalization of 392.93 Billion.
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women’s health fields, nutritional and over-the-counter pharmaceutical products. The company’s Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women’s health products. Johnson & Johnson is based in New Brunswick, New Jersey.
The stock traded between $118.62 and $148.44 over 1-Year time period showing its price to sales ratio of 4.83. Johnson & Johnson (NYSE:JNJ) is currently showing an INCREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $4.18 and 200-Day Simple Moving Average of $11.38. Its Price to Free Cash Flow is 43.03 and Price to Book of 6.08.
Analyst’s recommended the stock as 2.3 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Johnson & Johnson (NYSE:JNJ) reported its Actual EPS of $2.05/share. The analysts offering Earnings Estimates for the company were believing that Johnson & Johnson could bring EPS of $2.03/share. The difference between Actual EPS and Estimated EPS was 0.02 Percent. Thus showing an Earnings Surprise of 1 Percent.
British American Tobacco p.l.c. (NYSE:BTI)
In the last trading session, British American Tobacco p.l.c. (NYSE:BTI) added its value by 3.25% closing at the price of $35.53. The stock currently has market capitalization of 80.51 Billion, with average volume of 3.17 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently British American Tobacco p.l.c. (NYSE:BTI) is showing beta of 1.12. This particular value of beta suggests that British American Tobacco p.l.c. (NYSE:BTI) has historically moved 112% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for British American Tobacco p.l.c. (NYSE:BTI) is at $16.29.
The stock currently has RSI of 32.67. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
British American Tobacco is the holding company of a group of companies which manufacture, market and sell tobacco products.
British American Tobacco p.l.c. (NYSE:BTI) topped its 52-week high price of $71.44 on 01/23/18 and 52-Week Low Price of $34.34 on 11/20/18. The Stock currently has P/E (price to earnings ttm) of 2.18 and Weekly volatility of 1.87% and monthly volatility of 2.49% respectively.